|
Novartis launches fully interactive Facebook ‘Retina App’ on World Sight Day to raise awareness of retinal disease
|
10 October 2013 |
|
Secukinumab (AIN457) showed superiority over Enbrel®
|
04 October 2013 |
|
Malaria No More and Novartis launch Power of One, a global digital fundraising campaign to help eliminate malaria deaths
|
23 September 2013 |
|
Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free
|
19 September 2013 |
|
Novartis announces an exclusive global licensing and research collaboration with Regenerex
|
06 September 2013 |
|
Novartis holds annual healthcare entrepreneur competition
|
28 August 2013 |
|
Novartis first company accredited with global CEO Cancer Gold Standard
|
11 August 2013 |
|
Novartis study of Afinitor® in advanced liver cancer does not meet primary endpoint of overall survival
|
07 August 2013 |
|
Novartis delivered growth across all divisions in second quarter
|
22 July 2013 |
|
Novartis and Biological E agree to deliver affordable vaccines for typhoid and paratyphoid A fevers to developing world
|
08 July 2013 |